Art greets his audience from various time zones and introduces the night’s guest, Dr. Klatz, who is working on extending human lifespan. Art encourages listeners to visit the Coast to Coast AM website for updates and a new video related to controversial theories about President Bush. He then introduces Bonnie Crystal, an explorer and technologist, who is currently in Peru. Bonnie has been exploring deep caves in remote areas and is on a break in Lima. Art and Bonnie discuss her expedition, the challenges she faces, and her motivations for exploring unknown caves. Bonnie shares insights into her current expedition and the discoveries she hopes to make.
Bonnie explains that exploring caves makes her feel more alive and fascinated by the unknown beneath the Earth. She describes the challenges of working at high altitudes in the Andes, specifically at 14,000 feet, and the physical demands of climbing up and down thousand-foot ropes. Despite the fear of death and potential dangers like earthquakes, she emphasizes that caves tend to be stable and that careful navigation minimizes risks. Bonnie shares a significant discovery of cave writings and pictographs that resemble Chinese and Japanese kanji, suggesting ancient connections between Asia and South America. She mentions an archaeologist’s upcoming examination of the writings and discusses methods like carbon dating to estimate their age. Bonnie also talks about visiting a 5,000-year-old peaceful city in Peru with pyramids, drawing parallels with the pyramids in Egypt and pondering the synchronicity of ancient civilizations developing similar structures.
Bonnie recounts finding a cave under Machu Picchu with carvings resembling alien heads, which she plans to upload to her website. She and Art discuss the possibility of telepathy or intervention in ancient civilizations’ simultaneous inventions, citing the example of similar structures like pyramids in Peru and Egypt. Bonnie describes a cavern filled with bones of prehistoric animals and humans, suggesting they fell into the pit. She talks about the anticipation and fear when descending into deep, dark caves, hoping the rope doesn’t break.
Art talks about Bonnie being a ham radio operator who has communicated with him from remote areas in Peru. Bonnie mentions her next expedition will be to the Chachapoyas region, known for its pre-Inca civilization and numerous caves. They discuss the similarities between the caves Bonnie explores and sinkholes shown in Discovery Channel documentaries, emphasizing the unique biology found in these subterranean environments. Bonnie explains how light penetration in large cave entrances allows for some plant growth and describes discovering new species of plants and animals in these ancient, preserved ecosystems. She describes finding various forms of life, including snakes, fish, frogs, and bats, as well as stunning mineral formations like gypsum crystals, which create surreal, jewel-like environments inside the caves.
Art and Bonnie discuss the formation of caves through water erosion, tectonic movements, and geological forces that uplifted the limestone to high altitudes. They talk about the dangers of flash floods in caves and the need for quick evacuation to higher ground if water rushes in. Bonnie describes the lengthy and challenging nature of her expeditions, involving mule packs, horses, and long treks through the jungle to reach remote caves. She emphasizes the strong bond and reliance on her team during these explorations. Art expresses awe at the physical demands and the unknown depths they encounter. Bonnie explains the need for training and preparation for such demanding work, mentioning how caves can vary in temperature depending on their environment and depth. She notes that most caves maintain a temperature similar to the surface, but deep mines can get very hot due to proximity to magma.
Art and Bonnie discuss the hazards of exploring steam vent caves, such as those in Hawaii, where they must carefully time their explorations between bursts of steam. Despite the dangers and the unknowns, Bonnie expresses her excitement about future explorations and the potential of discovering deep, seemingly bottomless caves. Art admires her dedication and adventurous spirit, acknowledging that he couldn’t imagine undertaking such risks himself. Bonnie hopes to continue her expeditions, fueled by the discovery of thousands of caves in a specific area. She plans to maintain communication with Art via ham radio during her travels.
Art introduces Dr. Ronald Klatz, a leading authority in anti-aging medicine and president of the American Academy of Anti-Aging Medicine. Dr. Klatz discusses the potential of stem cell research in treating degenerative diseases and highlights the significant technological advancements in anti-aging therapies. He mentions the progress in nanotechnology and the development of laboratory-on-chip technology, which can provide detailed genetic information from a single drop of blood. Dr. Klatz emphasizes the importance of early detection in preventing diseases and tailoring treatments to individual risk profiles. He describes undergoing a PET scan, a cutting-edge nuclear medicine technique that creates a 3D image of the body to detect diseases early.
Dr. Klatz describes the accuracy of PET scans in detecting tumors and his personal experience with the technology, which reassured him about his health. He and Art discuss the potential of a significant investment in stem cell research and anti-aging medicine, suggesting that breakthroughs could happen within five years with adequate funding. Dr. Klatz believes that with a budget of $5 billion per year, or even as little as $500 million per year, significant improvements in quality of life and lifespan could be achieved. He explains that current anti-aging medicine can already reduce the biological age of individuals by 5 to 10 years through various therapies. Dr. Klatz envisions the possibility of a “magic bullet” in the future that could stop aging by combining nanotechnology, stem cells, and DNA repair technology.
Dr. Klatz discusses the concept of maintaining a state of perpetual youth, acknowledging it’s a far-off technology but potentially achievable within 30-35 years. He explains that advancements will likely come in increments, progressively eliminating diseases and improving quality of life. They talk about the emergence of new diseases, particularly from densely populated areas like China, and the ongoing battle against them. Despite new diseases, Dr. Klatz asserts that significant progress is being made against major killers in the first world. The conversation shifts to ethical considerations, such as when life begins, noting that views vary widely based on religious and philosophical beliefs.
Dr. Klatz explains the varying beliefs about when life begins, emphasizing that it depends on individual religious and philosophical views. He shares his perspective, suggesting that a fetus becomes a viable human life after the second trimester. The conversation then shifts to stem cells, with Dr. Klatz describing them as pluripotent cells capable of becoming any of the 200 different types of cells in the body. He explains that stem cells are derived from fertilized eggs and develop into various cell types through complex chemical signals during growth. Art and Dr. Klatz discuss the potential of using stem cells to repair damaged heart tissue, highlighting that these cells inherently know how to repair specific tissues when injected.
Dr. Klatz continues to explain that stem cells can naturally find and repair damaged tissue, such as heart or brain tissue, without needing specific instructions. This capability has already been demonstrated in humans and animals, proving the immense potential of this technology. He addresses the controversy surrounding stem cell research, noting that embryonic stem cells are most potent and versatile when retrieved early, around five days after conception. These cells can be amplified and grown in large quantities, making the ethical debate about harvesting them from aborted fetuses unnecessary.
Dr. Klatz explains that there are three primary tissue types in the body: endoderm, mesoderm, and ectoderm. Each type develops into specific organs and tissues, and stem cells can differentiate into these types. For instance, endoderm cells can become the pancreas or liver, mesoderm cells can become bone marrow or blood cells, and ectoderm cells can become neurons or skin. He mentions that after around 14 days, stem cells can be more specifically directed to become particular cell types, such as brain cells for Alzheimer’s treatment.
Art and Dr. Klatz discuss the possibility of extracting stem cells from amniotic fluid without harming the fetus, highlighting the potential for stem cell research without ethical concerns. Dr. Klatz suggests that the opposition to stem cell research may stem more from political and financial motives than ethical ones.
Dr. Klatz elaborates that stem cells can be derived from adults and other sources, not just embryos, making the ethical debate about embryonic stem cells somewhat spurious. He notes that stem cells can be harvested without harming fetuses, emphasizing that in vitro fertilization labs routinely handle and discard fertilized eggs without controversy. Dr. Klatz believes that resistance to stem cell research comes from a mix of ethical concerns and resistance to new technology from established medical institutions.
Art presses Dr. Klatz to articulate the opposition’s arguments against stem cell research. Dr. Klatz acknowledges that while some opposition is based on ethical beliefs about human life, much resistance also comes from fear of disrupting the existing medical establishment. He mentions that other countries, including those with strong Christian values, are investing heavily in stem cell research, indicating that the controversy is not solely based on religious grounds.
Dr. Klatz elaborates on the global investment in stem cell research, highlighting significant projects in India, Australia, and even private funding initiatives in the U.S., such as Harvard’s $100 million research center. He explains that while private money can still fund stem cell research, public funds are prohibited from being used for embryonic stem cell research in the U.S., which effectively stifles significant scientific progress due to the potential loss of federal funding for universities.
He argues that opposition to stem cell research stems from a combination of anti-abortion sentiments and pharmaceutical industry interests. The pharmaceutical industry, in particular, may fear the financial impact of cures that stem cells could provide, as their business model relies on treating chronic diseases rather than curing them. Dr. Klatz points out that there have even been attempts to pass international legislation to criminalize stem cell research, indicating the extent of the opposition.
Despite the controversy, he clarifies that the stem cells used in research are typically derived from embryos created in laboratories, not from terminated pregnancies, and these embryos have no chance of developing into human beings without extraordinary and unethical measures. This nuanced understanding often gets lost in the public debate, which is influenced by both ethical concerns and vested financial interests.
Dr. Klatz explains that reproductive cloning involves implanting a blastocyst into a woman’s womb, which most scientists oppose for bioethical reasons. He then shifts to promoting the American Academy of Anti-Aging Medicine’s upcoming international congress in Chicago, inviting listeners to attend and learn about advancements in stem cell technology and anti-aging medicine.
Art asks if heart patients can currently receive stem cell treatments. Dr. Klatz responds that while still controversial in the U.S., some private doctors and research centers offer such treatments, with more accessible options overseas. He describes different techniques for injecting stem cells to regenerate heart tissue, noting that in animal models, up to a third of damaged heart tissue has been regenerated, while in humans, about 10% regeneration has shown significant improvement in patients’ conditions.
Dr. Klatz explains that the disparity between lab results and human outcomes is due to the early stage of the technology and differences in how aggressively animals and humans can be treated. He concludes by highlighting the success of stem cell treatments in reversing diabetes in many patients.
Dr. Klatz reveals that stem cell technology has shown promising results in reversing diabetes and significantly improving conditions for Parkinson’s disease patients. He emphasizes that stem cell research has been ongoing for decades, often in the form of bone marrow transplantation. Critics argue that nanotechnology might soon replace stem cell research, but Dr. Klatz insists that while nanotechnology holds potential, it is still many years away from being a practical alternative. In contrast, stem cell treatments are available now and can offer immediate benefits.
Dr. Klatz notes that countries like Singapore are leading in stem cell research, with government-sponsored programs focusing on various applications, including blindness treatment. He suggests that the U.S. lags due to restrictions on public funding for embryonic stem cell research. When asked if current technology could have saved Ronald Reagan from Alzheimer’s complications, Dr. Klatz states that while some treatments have shown potential in slowing the disease, no definitive cure exists yet. He mentions a vaccine that had promising results in early trials but was halted due to adverse side effects.
Dr. Klatz explains Alzheimer’s disease, detailing how the buildup of beta-amyloid protein in the brain leads to inflammation, which in turn causes brain damage. This inflammation prompts white blood cells to attack the protein but also damages healthy brain tissue, resulting in cognitive decline. He mentions that anti-inflammatory drugs like aspirin or Motrin have been linked to lower incidences of Alzheimer’s, as inflammation plays a key role in the progression of many diseases, including certain cancers.
Dr. Klatz highlights the promise of anti-aging medicine, which aims to improve quality of life and extend lifespan by leveraging biotechnology. He notes that the current moratorium on federal funding for stem cell research, particularly for embryonic stem cells, has a chilling effect on the entire field, hindering progress and investment.
Art and Dr. Klatz discuss the broader implications of this moratorium, suggesting that it may be influenced by more than just religious opposition. Dr. Klatz hints at potential pharmaceutical industry interests that may resist cures in favor of ongoing treatments. The lack of public protests against stem cell research compared to abortion indicates that other factors might be at play in stalling this promising technology.
Dr. Klatz acknowledges the complexities and interests at play in the debate over stem cell research funding. He believes that while pharmaceutical companies are not actively funding or endorsing stem cell research, their focus on profitable treatments for chronic diseases rather than cures may contribute to their reluctance. Despite this, he remains hopeful that scientific progress cannot be stopped, even if major breakthroughs happen overseas.
Art and Dr. Klatz discuss the upcoming 12th International Congress on Anti-Aging Medicine in Chicago, where doctors and scientists from around the world will present the latest advancements in stem cell technology, nanotechnology, and other anti-aging treatments. Dr. Klatz emphasizes the importance of public support and awareness for these technologies, offering a special deal for listeners to attend the conference and receive various anti-aging resources.
Dr. Klatz expresses his belief that significant anti-aging breakthroughs will happen within his lifetime, reflecting on his own biological age and the ongoing advancements in the field. He remains optimistic about the future of anti-aging medicine and its potential to improve and extend human life.
Dr. Klatz believes that advancements in stem cells, nanotechnology, and DNA repair could extend the lifespan of those under 65 by 20 years. These technologies are on the verge of becoming widely available. He acknowledges the potential societal impacts of extended lifespans, such as overpopulation and strain on resources, but notes that developed countries already face declining birth rates, which could mitigate these concerns.
Art and Dr. Klatz discuss the strain on social security and government fears regarding anti-aging technologies. Dr. Klatz points out that in many developed nations, population growth is already negative when excluding immigration. They also touch on the ethical and logistical implications of significantly extended lifespans, such as long-term incarceration.
Dr. Klatz emphasizes that despite some criticisms, pharmaceutical companies do provide valuable contributions. However, he believes the current system has flaws that need addressing. He highlights the importance of public support and awareness for anti-aging technologies to drive progress and ensure these advancements benefit everyone.
Dr. Klatz discusses the broader health industry, highlighting that it is driven more by financial interests than humanitarianism. This financial motivation likely contributes to the lack of support for stem cell research from pharmaceutical companies and other related industries. He explains that these companies are focused on short-term profits from ongoing treatments rather than long-term cures that could disrupt their business models.
Dr. Klatz mentions that anti-aging and preventive medicine often face opposition from vested interests, which fund detractors to discredit these fields. Despite this, the American Academy of Anti-Aging Medicine has grown significantly, training thousands of doctors worldwide.
A caller named Gian joins the conversation, emphasizing that the controversy mainly revolves around embryonic stem cells, while there is broad support for adult stem cells. Dr. Klatz acknowledges the caller’s point and explains that embryonic stem cells are crucial due to their pluripotency, which allows them to differentiate into various cell types and be less likely recognized as foreign by the immune system. This makes embryonic stem cells more versatile and valuable for research and treatments.
Dr. Klatz introduces the concept of somatic cell nuclear transfer, where a patient’s DNA could be injected into an empty egg cell to grow personalized stem cells for transplantation. This technique, while promising, remains in the realm of advanced research and faces ethical and legal challenges.
Dr. Klatz explains that while somatic cell nuclear transfer (SCNT) involves injecting a person’s DNA into an empty egg cell to grow personalized stem cells, it remains a complex and somewhat gray area legally. He emphasizes that as long as these cells are not implanted into a womb, they cannot develop into a human being.
A caller asks about stem cell treatment for ALS (Amyotrophic Lateral Sclerosis). Dr. Klatz shares that recent studies in mice have shown that stem cells can significantly slow the progression of ALS, translating to potentially slowing the disease in humans by several years.
Art asks about the potential for stem cells to restore sight to a blind person. Dr. Klatz mentions ongoing research aiming to regrow corneas and repair retinas using stem cells. He explains that injecting the appropriate cell lines into the eye might regenerate damaged retinal tissue.
Dr. Klatz discusses other promising applications of stem cells, such as regenerating cartilage in osteoarthritis patients and repairing heart scars. He clarifies that while stem cells can repair some damage, they currently cannot completely reconfigure congenital heart anomalies.
A caller named Rosie asks about her son, who had a brain tumor and is now severely disabled. Dr. Klatz mentions that combining hyperbaric oxygen therapy with stem cell therapy is being explored for repairing brain tissue in children with neurological damage, such as cerebral palsy or brain stem stroke. Hyperbaric therapy involves increasing atmospheric pressure to saturate the blood with oxygen, potentially stimulating tissue repair.
Dr. Klatz discusses how hyperbaric oxygen therapy (HBOT) can help people with neurological issues by driving more oxygen into the tissues, which can aid in healing. This therapy, combined with early stem cell treatments, has shown promising, though not miraculous, results in improving conditions in patients, including children with brain damage.
A caller from Reno, Nevada, asks about the potential of stem cell research to address mental illness. Dr. Klatz explains that stem cells could help if the mental illness is due to brain tissue damage rather than genetic factors. Stem cells can find damaged tissue and assist in its regeneration, which could benefit those with mental illness resulting from head injuries or chemical imbalances.
Art and Dr. Klatz reflect on the broad potential of stem cell research, suggesting that if it proves effective for Alzheimer’s, it could likely help other brain diseases as well. They continue to promote the upcoming International Congress on Anti-Aging Medicine in Chicago, emphasizing the accessibility of the information and the benefits of attending for both professionals and the general public. Dr. Klatz mentions the various resources available at the conference, including his book and a CD-ROM with years of anti-aging research.
Dr. Klatz discusses the logistical aspects of attending the anti-aging conference, emphasizing the value attendees will receive for a $19 registration fee. He provides contact details for those interested in registering.
Art and Dr. Klatz discuss the economic realities of medical advancements. While Dr. Klatz acknowledges that new technologies will be costly initially, he stresses the importance of having these advancements available, even if expensive. He notes that the cost of anti-aging programs has significantly decreased over the years, making them more accessible.
They discuss the potential for large-scale breakthroughs in anti-aging and stem cell research to carry high costs due to patenting and commercialization. However, Dr. Klatz expresses hope that the international nature of these advancements will prevent any single entity from monopolizing them, comparing it to the democratizing effect of the internet.
A caller inquires about using stem cells for degenerative spinal issues and sciatica. Dr. Klatz explains that stem cells show promise for regenerating cartilage and treating spinal problems. He also mentions existing non-surgical treatments, such as injecting a putty-like material into the spine to act as a shock absorber.
Dr. Klatz addresses a question about Canada’s regulations on embryonic stem cells, admitting he is not well-versed in Canadian law but focusing on the promising scientific applications. Regarding HIV, Dr. Klatz explains that reconstituting the immune system with stem cells could help maintain immune function and prevent AIDS, as some people with HIV do not develop AIDS due to a resilient immune system.
Dr. Klatz discusses the emerging understanding that many diseases, including certain cancers and heart disease, might be initiated by viruses. He shares a recent study where embryonic stem cells helped regenerate a severed spinal cord in mice, leading to partial mobility recovery.
Art and Dr. Klatz explore the potential for stem cells to fully repair damaged tissues. Dr. Klatz explains that successful tissue repair requires the damaged tissue to signal for repair, which can be complicated by scarring. Additionally, stem cells need cofactors and specific signaling molecules, such as IGF-1, to effectively facilitate repair. The scientific community is still in the early stages of discovering these factors and optimizing stem cell lines for various types of tissue repair.
They discuss the possibility of vaccines targeting viruses that contribute to diseases like heart disease. Dr. Klatz mentions reports linking chlamydia infections to atherosclerotic plaques, suggesting that eradicating such infections could potentially prevent the associated inflammatory processes leading to heart disease.
Dr. Klatz discusses the exciting possibilities of genetic engineering in conjunction with stem cell research. He mentions that specific genetic material can now be injected into hearts to grow new blood vessels, potentially offering a way to overhaul the heart at an older age, regardless of existing atherosclerosis. This marks a significant step toward practical immortality, with lifespans potentially extending well beyond 100 years.
He emphasizes that while living to 100 was once considered mythical, it is now increasingly common, with over 100,000 Americans aged 100 or older. The conversation touches on the advancements that could come any day, which would fundamentally change human aging and the risks associated with degenerative diseases.
Art and Dr. Klatz reflect on society’s ability to adapt to these groundbreaking discoveries, concluding that people will adjust to whatever advancements come their way. Dr. Klatz expresses his hope that these technologies will allow for a future where people can enjoy longer, healthier lives.
Art thanks Dr. Klatz for his insights and participation in the show, looking forward to the potential of an “ageless society.”